eRapa (encapsulated rapamycin)
MTX230-301
Phase 3 small_molecule active
Quick answer
eRapa (encapsulated rapamycin) for Familial Adenomatous Polyposis (FAP) is a Phase 3 program (small_molecule) at Biodexa Pharmaceuticals Plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biodexa Pharmaceuticals Plc
- Indication
- Familial Adenomatous Polyposis (FAP)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active